Safety And Efficacy Of Rescriptor In Patients For Human Immunodeficiency Virus (HIV) Patients
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
The objective of this surveillance is to collect information about 1) adverse drug reaction
not expected from the Local Product Document (LPD) (unlisted adverse drug reaction), 2) the
incidence of adverse drug reactions in this surveillance, and 3)factors considered to affect
the safety and/or efficacy of this drug.